1.
J Allergy Clin Immunol Glob
; 3(3): 100251, 2024 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38706460
RESUMO
A patient presented with overlapping clinical and laboratory features of 2 rare autoinflammatory diseases, NLRP1-associated autoinflammation with arthritis and dyskeratosis and familial multiple self-healing palmoplantar carcinoma. Her severe inflammatory attack was treated with the IL-1 receptor-α inhibitor anakinra along with the Janus kinase inhibitor ruxolitinib. Three years into the treatment, the patient's inflammatory symptoms are completely in remission.